Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With Asthma [Phase 1]
This Phase 1 study compared single-dose pharmacokinetics and pharmacodynamics of two formulations of abediterol in patients with asthma; res…
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma [Phase 3]
Phase 3 trial evaluating the fixed-dose combination of fluticasone furoate and vilanterol versus standard asthma therapy. Results have been …
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects [Phase 1]
A Phase 1 trial evaluating tolerability, pharmacokinetics, and the food effect of ZL-2102 in healthy male subjects.
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Patterns of Neurocircuitry Activation In Severe Asthma
This ClinicalTrials.gov entry notes that a study examining patterns of neurocircuitry activation in severe asthma has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Training Parents by Acceptance and Commitment Therapy for Managing Childhood Asthma Care [NA]
Clinical trial update describing a completed study that evaluated training parents in Acceptance and Commitment Therapy to improve childhood…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: AVAD: Asthma With Small Airways Dysfunction [NA]
An AVAD trial evaluating asthma with small airways dysfunction, sponsored by Hospices Civils de Lyon, has been terminated.
-
CLINICAL_TRIALS research · 2019-01-23Clinical Trial Update: Impact of Air Pollution on Chronic Respiratory Diseases
This clinical trial update from Seoul National University Hospital describes a study examining how air pollution influences chronic respirat…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) [Phase 3]
Phase 3 trial evaluating whether 18-month levocetirizine treatment in infants with atopic dermatitis and grass pollen/house dust mite sensit…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma [Phase 2, Phase 3]
This clinical trial update reports results from Phase 2 and Phase 3 studies evaluating the bronchodilator effects and safety of glycopyrroni…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Using Question Prompt Lists During Pediatric Asthma Visits to Increase Adolescent Involvement [NA]
A completed clinical trial evaluating the use of question prompt lists during pediatric asthma visits to increase adolescent involvement.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection [Phase 2]
Phase 2 trial evaluating the efficacy, safety, and tolerability of 14 days of once-daily inhaled interferon beta-1a in asthma patients after…
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma [Phase 3]
Phase 3 trial comparing Fluticasone Furoate/Vilanterol Inhalation Powder with usual ICS/LABA in persistent asthma has completed with results…
-
FDA approval · 2019-01-09FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
The FDA approved a supplemental application for PROAIR DIGIHALER (albuterol sulfate) submitted by Teva Respiratory, LLC. This action updates…
-
FDA approval · 2019-01-09FDA Approved: CINQAIR — Supplemental Application (Teva Respiratory, LLC)
FDA approved a supplemental application for CINQAIR (reslizumab) submitted by Teva Respiratory, LLC.
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids [Phase 2]
Phase 2 trial investigating tralokinumab for asthma inadequately controlled on corticosteroids has completed with posted results.
-
FDA approval · 2019-01-07FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline LL…
-
FDA approval · 2019-01-07FDA Approved: FLUTICASONE PROPIONATE DISKUS — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Propionate Diskus (NDA020833) submitted by Prasco Laboratories. The approval confirm…
-
FDA approval · 2019-01-07FDA Approved: BREO ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for BREO ELLIPTA (FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE) from GlaxoSmithKline LLC, resultin…
-
FDA approval · 2019-01-07FDA Approved: FLUTICASONE FUROATE ELLIPTA — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Fluticasone Furoate Ellipta submitted by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Heart Rate Variability Biofeedback: It's Role in Asthma Therapeutics [NA]
A completed clinical trial evaluating heart rate variability biofeedback as a therapeutic approach in asthma, with results posted in 2019.
-
FDA approval · 2018-12-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application to the Singulair (montelukast) NDA submitted by Organon LLC.
-
FDA approval · 2018-12-21FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for SEREVENT Diskus (salmeterol xinafoate) from GlaxoSmithKline.
-
FDA approval · 2018-12-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent Asthma [Phase 2]
Phase 2 trial update evaluating the efficacy of oral AB1010 in adults with severe persistent corticosteroid-dependent asthma completed.
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma [Phase 2]
Phase 2 trial evaluating MEDI9929 (AMG 157) for adult asthma has completed; results posted in 2018.